Primary Site >> Esophagus Cancer

Gene >> CDK6

  • 1995
  • 2001
  • 2006
  • 2010
  • 2011
  • 2012
  • 2013
  • 2015
Ref: Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.
PMID: 8595411
 Ref: Insufficient effect of p27(KIP1) to inhibit cyclin D1 in human esophageal cancer in vitro.
PMID: 11115553
 Ref: Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory.
PMID: 16952836
 Ref: Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array--comparative genomic hybridization.
PMID: 20620594
 Ref: Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.
PMID: 21352519
 Ref: Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma.
PMID: 22450065
 Ref: Antitumor effect of metformin in esophageal cancer: in vitro study.
PMID: 23229592
 Ref: miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells.
PMID: 25216463
Ref: Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
PMID: 25709052
Ref: Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway.
PMID: 26073339